AI In Endoscopy Market Revenue to Attain USD 21.65 Bn by 2035
Published: 30 Mar 2026
Author: Precedence Research
AI In Endoscopy Market Revenue and Trends 2026 to 2035
The global AI in endoscopy market revenue reached USD 2.14 billion in 2025 and is predicted to attain around USD 21.65 billion by 2035 with a CAGR of 26.04%. The rising prevalence of gastrointestinal disorders is driving market growth, highlighting the growing need for effective and advanced technology-based diagnostic and treatment solutions.
What Drives the AI in Endoscopy Market?
The growing number of cases of gastrointestinal (GI) disorders and colorectal cancer is significantly driving the global adoption of AI-powered endoscopy technologies. At the same time, advancements in robotic-assisted procedures are increasing the need for AI tools that can improve precision and provide real-time guidance during interventions. Additionally, the shift toward cloud-based endoscopy solutions is enabling easier remote diagnostics and centralized data management across hospitals. Ongoing improvements in deep learning, especially in image recognition and anomaly detection, are further encouraging the widespread use of AI in everyday endoscopic procedures.
Segmenta Insights
- By application, the gastrointestinal endoscopy segment led the market in 2025, driven by rising colorectal cancer and GI disorders. AI tools like CADe, along with real-time video analysis and image enhancement, improve accuracy, streamline workflows, and support earlier diagnosis, boosting adoption.
- By type of endoscopes, the flexible endoscopes segment accounted for a significant market share in 2025, largely because of their versatility and ease of use across different parts of the body. Healthcare professionals prefer them for their flexibility, better navigation, and improved patient comfort. They play an essential role in procedures like colonoscopies and bronchoscopies, where precise movement inside the body is crucial for accurate diagnosis and effective treatment.
- By endoscopy techniques, the endoscopic ultrasound segment held the largest market share in 2025, mainly due to its advanced imaging and highly accurate diagnostic capabilities. It provides clear, high-resolution images of deeper tissue layers, making it especially valuable in evaluating gastrointestinal disorders. Its ability to deliver real-time imaging and support therapeutic procedures further strengthens its importance, driving widespread adoption in clinical practice.
- By endoscopy imaging modalities, the white-light endoscopy segment accounted for the largest market share in 2025, largely due to its widespread use and strong presence in clinical settings. It provides a clear visualization that helps highlight vascular patterns and mucosal abnormalities, improving diagnostic accuracy. This makes it especially useful for detecting early-stage cancers, which play a crucial role in improving patient outcomes.
Regional Insights
North America dominated the AI in endoscopy market by holding the maximum share in 2025, driven by early technology adoption, strong healthcare spending, and established screening programs in the U.S. and Canada. Guidelines from key medical organizations support clinical practices, while advanced infrastructure, high AI adoption, ongoing R&D investments, and collaborations between companies and hospitals continue to drive innovation and broader clinical use.
Asia Pacific is expected to grow at the fastest rate in the market during the forecast period. This growth is driven by rising cases of GI diseases, especially colorectal and gastric cancers. Expanding healthcare systems in countries like China, Japan, and South Korea, along with a stronger focus on early diagnosis, are supporting this growth. Increasing adoption of AI-assisted colonoscopy, along with higher healthcare spending and improved clinical training, is also encouraging wider acceptance of AI-based workflows in the region.
AI In Endoscopy Market Coverage
| Report Attribute | Key Statistics |
| Market Revenue in 2025 | USD 2.14 Billion |
| Market Revenue by 2035 | USD 21.65 Billion |
| CAGR from 2026 to 2035 | 26.04% |
| Quantitative Units | Revenue in USD million/billion, Volume in units |
| Base Year | 2025 |
| Focasted Year | 2026 ro 2035 |
| Segments Covered | Packaging Type, Raw Material, Technique, and End-Use |
Recent Developments
- On February 24, 2026, Olympus announced that the EAGLE trial proved CADDIE AI effectively detects high-risk and sessile serrated lesions. This cloud-based system significantly improves flat adenoma identification, establishing AI as the new clinical standard.(Source: https://www.olympus-europa.com)
Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/8153
You can place an order or ask any questions, please feel free to contact us at sales@precedenceresearch.com |+1 804 441 9344